The News Of Tomorrow, Today
The News Of Tomorrow, Today
Epipen
For people with severe allergies, having an EpiPen can mean the difference between life and death. Because there’s no generic alternative, EpiPen manufacturer Mylan just keeps jacking up the price and ripping off patients. They also seem to have ripped off the US government. Today, a probe by the US…
The stock price of Mylan is soaring, but the pharmaceutical company might not be out of the woods yet. After a winter of bad headlines, Congressional testimony and agreements to pay back millions to the US government, the Pentagon is looking at how much Mylan has been overcharging since 2008.
Two weeks ago, Mylan CEO Heather Bresch got up in front of Congress and lied about how much profit the pharmaceutical company makes on the EpiPen. And Congress is pissed.
There are no more articles to be viewed
Haven't registered?
Sign up here
Lost your password?
Click here to reset
Back to Login?
Click here
Subscribe to our newsletter!
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.